Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

75.10 +1.09 (+1.47%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,516,090
Open 74.37
Bid (Size) 75.11 (1)
Ask (Size) 75.70 (1)
Prev. Close 74.01
Today's Range 73.88 - 75.52
52wk Range 64.41 - 104.83
Shares Outstanding 1,319,574,744
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is CVS stock ready for a rebound?
After consolidating from this year's selloff, for those of us on the sidelines, this is about as clear a low as you can expect to see. 
Via MarketBeat
The Fastest Growing Brands In 2023: ChatGPT, Starry, Zelle, Shein, Tesla, Hulu And More
Looking at the list of the fastest growing brands in the United States, including a break down of top brands by age group. 
Via Benzinga

Performance

YTD
-19.17%
-19.17%
1 Month
+9.24%
+9.24%
3 Month
+14.06%
+14.06%
6 Month
+4.65%
+4.65%
1 Year
-26.75%
-26.75%

More News

Read More
7 Dividend-Paying Healthcare Stocks for Income Investors
Via InvestorPlace
A Closer Look at CVS Health's Options Market Dynamics
Via Benzinga
Why CVS Health Jumped Nearly 4% Today
Via The Motley Fool
Secure Your Retirement With These 3 Dividend Stocks
Via InvestorPlace
Topics Retirement
Exposures Pension
Why CVS Health Stock Rallied Wednesday Morning
Via The Motley Fool
CVS Stock Alert: 3 Reasons Why CVS Health Is Up Today
Via InvestorPlace
CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus
Via Talk Markets
Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'
Via Benzinga
Drugstore Chain CVS Health's Move to Simplify Drug Pricing Gives Peek Into FY24 Outlook
Via Benzinga
Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Why Realty Income Stock Jumped 14% in November
Via The Motley Fool
Silent Winners: 7 Low-Buzz Stocks With High Potential
Via InvestorPlace
Mega merger in the works? Humana, Cigna explore big deal
Via MarketBeat
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
Via InvestorPlace
Health Insurance Stocks Cigna (CI), Humana (HUM) Eye Merger
Via InvestorPlace
What's Going On With CVS Stock Today?
Via Benzinga
Companies That Grow Through Acquisitions: Pros And Cons
Via Talk Markets
What's Going On With Healthcare Insurance Giant Cigna Stock Today?
Via Benzinga
3 No-Brainer Stocks to Buy With $100 Right Now
Via The Motley Fool
Teva Pharma is the way to play the re-rise of generic drugs
Via MarketBeat
7 Monthly Dividend Stocks to Buy and Hold for Steady Returns
Via InvestorPlace
5 Telehealth Stocks That Have Nothing But Upside
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.